What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

Breakthrough publication: diabetes screening with AGE Reader

Groningen, the Netherlands. November 22, 2017.

Recently a new breakthrough publication about the AGE Reader was published. It concerns an analysis of 79.248 subjects of the LifeLines study, a longitudinal cohort study with 167.000 participants. The aim of this study was to investigate whether the AGE Reader would improve the FINDRISC model in detecting undiagnosed diabetes. In addition a simplified model with only the AGE Reader, BMI and age was tested.

In this paper the authors conclude that the AGE Reader measurement significantly improves the performance of the FINDRISC score in detecting diabetes. Furthermore, the simplified model (only AGE Reader, BMI and age) was shown to have a similar performance for diabetes detection compared to the full FINDRISC.

Please click here for the full-text version of this paper.

What are the key messages of this validation paper for the AGE Reader? 

  1. This study provides strong clinical validation for a broad application of the AGE Reader as a non-invasive screening tool to detect diabetes.
  2. This study provides a clinical validation in a huge study group of almost 80.000 subjects.
  3. This study is performed in general population and not in a specific patient group.

Share this link on:

Latest news items

  1. Breakthrough publication: diabetes screening with AGE Reader 24 November 2017
  2. AGE Reader product updates at EASD 2017 – Lisbon 13 September 2017
  3. MSP bodmann GmbH appointed as new distributor in Germany 29 June 2017
  4. New key publication: large scale study in metabolic syndrome 13 June 2017
  5. Diagnoptics appoints DiosPharma as the new Korean distributor 7 November 2016
  6. Visit Diagnoptics at the EASD congress 2016 in Munich 26 August 2016
  7. Selista appointed as new Japanese distributor for the AGE Reader mu 19 May 2016
  8. Diagnoptics bei dem DDG Kongress in Berlin 16 April 2016
  9. Diagnoptics receives Chinese market approval for AGE Reader SU 12 February 2016
  10. New patent granted to Diagnoptics in Japan and EU. 7 January 2016
  11. Diagnoptics receives Japanese market approval for AGE Reader mu. 11 September 2015
  12. Diagnoptics nominated for Deloitte Technology Fast50 7 September 2015
  13. Scientific review emphasises need for AGE measurements and interventions 16 July 2015
  14. Dutch government supports Diagnoptics and CTMM research project 6 July 2015
  15. Key publication: AGE Reader predicts amputation 5 May 2015
  16. New AGE Reader video available: quick start guide and user instructions. 3 April 2015
  17. Diagnoptics appoints Forel Medical as new Polish distributor 3 March 2015
  18. Diagnoptics appoints Microcaya as new Spanish distributor 6 February 2015
  19. Diagnoptics appoints ANL Produkter AB as new Swedish distributor 8 December 2014
  20. Exciting video: AGE Reader clinical case study 19 September 2014
  21. Review about AGE Reader in assessing CV risk and risk of diabetes 5 September 2014
  22. Excellent presentation about Advanced Glycation Endproducts (Dutch) 1 August 2014
  23. Editorial confirms added value of AGE Reader in atherosclerosis 25 March 2014
  24. Breakthrough publication: AGE Reader in atherosclerosis 11 March 2014
  25. German review AGE Reader 27 January 2014
  26. Upcoming Conferences 20 January 2014
  27. DiagnOptics moved to another location. 1 January 2014
  28. AGE Reader on national television 14 October 2013
  29. A.J. Smit appointed professor at the UMCG 23 September 2013
  30. Visit DiagnOptics at the EASD 2013 15 August 2013
  31. Clinical validation Diab-spot published 12 July 2013
  32. DiagnOptics receives CE mark approval for AGE Reader mu 17 May 2013
  33. DiagnOptics to show new product at international diabetes meetings in 2013 7 December 2012
  34. AGE Reader presented at German national diabetes conference in Berlin. 23 November 2012
  35. Successful introduction of the AGE Reader mu 22 October 2012
  36. Important role of AGE Reader shown in recent international publications 30 July 2012
  37. DiagnOptics present at the EASD 2012 in Berlin 20 July 2012
  38. DiagnOptics receives Health Canada approval for Diab-spot 1 May 2012
  39. DiagnOptics and PATH partner on project on diabetes screening in India 6 February 2012
  40. New product for diabetes detection, Diab-spot, introduced in Madrid. 19 April 2011
  41. DiagnOptics receives Health Canada approval for the AGE Reader. 15 March 2011
  42. DiagnOptics receives ISO 13485 certification. 1 June 2010
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a